Pancreatic adenocarcinoma is one of the leading ... contrast-enhanced multidetector computed tomography, magnetic resonance imaging and integrated positron emission tomography/computed tomography ...

The prevalence of mutations that can predispose to pancreatic adenocarcinoma (PDAC) remains unclear, especially in underrepresented populations. Here, the authors create a germline mutation map of ...

A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC), allowing insights into interactions between tumour ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

However, the safety and efficacy of these vaccine modalities remains unclear in pancreatic cancer patients. Methods ... then every two months during the treatment to monitor the changes in lesion ...

The test – dubbed PAC-MANN – has been developed at Oregon Health and Science University A novel blood testing technique could ...

Sandra Pennell; Senior Vice President - Finance, Chief Accounting Officer, Executive Officer; Delcath Systems Inc Thank you and once again, welcome to Delcath Systems fourth quarter in full year 2024 ...

This study shows that engineered E. coli Nissle 1917 producing indole-3-acetic acid (IAA), an AhR agonist, modulate the tumor ...

ScaleUps Ventures, a leading UK-based Health and Social Care startup accelerator announced its 2025 cohort of 11 pioneering companies to deliver on the innovation needs of the NHS and private sector.

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...